3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
2
Barrett Esophagus
2
Thyroid Nodule
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Lung Neoplasms
1
Hypoxia
1
Head and Neck Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Cardiotoxicity
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasm Female
1
Adenocarcinoma
1
Interventions
fluoroazomycin arabinoside
3
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
3
pimonidazole
2
Propofol
2
Blood Specimen Collection
2
gadobutrol
1
Sevoflurane
1
Radiotherapy
1
Pancreaticoduodenectomy
1
Oxygen
1
Ketamine
1
Gemcitabine
1
Furosemide
1
Exercise
1
Diagnostic Imaging
1
Biopsy
1
4-methylbenzenesulfonic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hypoxia
×
Diagnostic Imaging
×
Clear all
NCT04001023
2019-08-07
OVANOX
Turku University Hospital
Phase NA
Unknown
40 enrolled